Immutep LTD – Class Action Investigation

Ahdoot Wolfson is investigating a potential lawsuit against Immutep Limited. It has been reported that Immutep misrepresented to investors the results of its TACTI-004 Phase III trial treatment for lung cancer patients. If you bought or sold Immutep securities based on the company’s representations about the trial treatment, you may have legal claims. Please fill out the form below, and we will contact you.